SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (9372)3/24/1999 10:13:00 PM
From: Bluegreen  Read Replies (1) | Respond to of 17367
 
George, my point. In my opinion I would expect no deaths in treated group in phase III unless there are unusual characteristics like the one that died in Phase II. Death and accruals, don't you think DSMB had number in mind for futility if deaths exceeded a particular number in treated group irrespective of number of deaths in placebo group?